Biotech product launch trends for emerging biopharma companies US EU

Biotech product launch activity by emerging biopharma companies is rising in the U.S., while European entries remain limited due to pricing and market complexity. Many first-time biotech product launch programs extend to Europe using solo or out-licensing models, with Switzerland emerging as a preferred regional base. For more info: https://www.zs.com/insights/us-novel-first-launches-implications-emerging-biopharma